{"disease":{"id":"non-proliferative-diabetic-retinopathy","name":"non proliferative diabetic retinopathy"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05222633","title":"Anti-VEGF in Real-world","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Wenbin Wei","has_results":false},{"nct_id":"NCT02718326","title":"Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":402,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":true},{"nct_id":"NCT05358080","title":"Study to Evaluate Efficacy and Safety of Entelon 50mg in Patients With Non-Proliferative Diabetic Retinopathy","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":396,"lead_sponsor_name":"Hanlim Pharm. Co., Ltd.","has_results":false},{"nct_id":"NCT06817265","title":"Clinical Study on the Efficacy and Safety of TNTL in the Treatment of Non-proliferative Diabetic Retinopathy","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":360,"lead_sponsor_name":"Beletalent (Zhuhai) Pharmaceutical Co., Ltd","has_results":false},{"nct_id":"NCT04103671","title":"Pars-plana Vitrectomy vs Panretinal Photocoagulation for Severe NPDR","phase":"NA","overall_status":"UNKNOWN","enrollment_count":272,"lead_sponsor_name":"Zhongshan Ophthalmic Center, Sun Yat-sen University","has_results":false},{"nct_id":"NCT05066230","title":"A Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 in Non-proliferative Diabetic Retinopathy (NPDR)","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":253,"lead_sponsor_name":"Kodiak Sciences Inc","has_results":true},{"nct_id":"NCT05852132","title":"Clinical Study on Prognosis of Patients With Severe NPDR Undergoing Vitrectomy","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":249,"lead_sponsor_name":"Fei Gao","has_results":false},{"nct_id":"NCT04636307","title":"Characterization of Retinal Disease Progression in Eyes With Non Proliferative Diabetic Retinopathy in Diabetes Type 2 Using Non-invasive Procedures (CHART)","phase":"","overall_status":"COMPLETED","enrollment_count":202,"lead_sponsor_name":"Association for Innovation and Biomedical Research on Light and Image","has_results":false},{"nct_id":"NCT07236645","title":"Efficacy and Safety of Ginkgo Biloba Extract EGb761® in Patients With Diabetic Retinopathy","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":200,"lead_sponsor_name":"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","has_results":false},{"nct_id":"NCT05681884","title":"Safety and Efficacy of Faricimab in Patients With NPDR","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":179,"lead_sponsor_name":"Greater Houston Retina Research","has_results":false},{"nct_id":"NCT03197870","title":"The TIME-2b Study: A Study of AKB-9778 (Razuprotafib), a Novel Tie 2 Activator, in Patients With Non-Proliferative Diabetic Retinopathy (NPDR)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":167,"lead_sponsor_name":"EyePoint Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT03597815","title":"Diabetic Macular Edema - Obstructive Sleep Apnea Relationship Study","phase":"","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"Uptown Eye Specialists","has_results":false},{"nct_id":"NCT03696810","title":"Characterization of Retinal Vascular Disease in Eyes With Mild to Moderate NPDR in Diabetes Type 2","phase":"NA","overall_status":"COMPLETED","enrollment_count":141,"lead_sponsor_name":"Association for Innovation and Biomedical Research on Light and Image","has_results":false},{"nct_id":"NCT02435862","title":"A Clinical Trial Designed to Evaluate the Safety and Efficacy Study of Luminate® in Inducing PVD (Posterior Vitreous Detachment) in Non-Proliferative Diabetic Retinopathy","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":105,"lead_sponsor_name":"Allegro Ophthalmics, LLC","has_results":false},{"nct_id":"NCT04692688","title":"Study of the Safety and Efficacy of APX3330 in Diabetic Retinopathy","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":103,"lead_sponsor_name":"Ocuphire Pharma, Inc.","has_results":false},{"nct_id":"NCT04511715","title":"Intravitreal Bevacizumab for Nonproliferative Diabetic Retinopathy","phase":"PHASE2, PHASE3","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Shahid Beheshti University of Medical Sciences","has_results":false},{"nct_id":"NCT05386160","title":"Phacoemulsification Combined With Intravitreal Injection of Ranibizumab Prevent Postoperative Capillary Non-perfusion Zone Progress in Non-proliferative Diabetic Retinopathy","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":96,"lead_sponsor_name":"Ruijin Hospital","has_results":false},{"nct_id":"NCT06951087","title":"Intravitreal and Intracameral DEX in NPDR","phase":"PHASE3","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":80,"lead_sponsor_name":"Affiliated Hospital of Nantong University","has_results":false},{"nct_id":"NCT05383209","title":"Study of EYP-1901 in Patients With Nonproliferative Diabetic Retinopathy (NPDR)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":77,"lead_sponsor_name":"EyePoint Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT06713720","title":"Remote Ischemic Conditioning for Non-Proliferative Diabetic Retinopathy","phase":"NA","overall_status":"RECRUITING","enrollment_count":68,"lead_sponsor_name":"Xuxiang Zhang, MD","has_results":false},{"nct_id":"NCT07230184","title":"To Evaluate the Efficacy and Safety of Combination Therapy With B55R1 and B55R2 Compared to B55R1 Monotherapy in Patients With NPDR","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":52,"lead_sponsor_name":"AJU Pharm Co., Ltd.","has_results":false},{"nct_id":"NCT03863535","title":"PRP vs PRP+IVC for Severe nPDR","phase":"NA","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"Ruijin Hospital","has_results":false},{"nct_id":"NCT06487845","title":"A Study to Learn How Safe BAY3283142 is When Taken as a Single Dose or as Multiple Doses in Healthy Chinese Participants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT06599684","title":"Study of INV-102 Ophthalmic Solution in Adults With Diabetic Macular Edema Associated With Non-proliferative Diabetic Retinopathy","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":19,"lead_sponsor_name":"Invirsa, Inc.","has_results":false},{"nct_id":"NCT07198815","title":"A Preliminary Exploratory Clinical Trial to Evaluate the Efficacy of NPDR-01 Eye Drops in the Treatment of Non-Proliferative Diabetic Retinopathy","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":10,"lead_sponsor_name":"Sichuan Academy of Medical Sciences","has_results":false}],"total":25},"guidelines":[],"source":"Drug Landscape verified database"}